Conference Coverage

VIDEO: Integrated care effective in first-episode psychosis


 

EXPERT ANALYSIS FROM THE APA ANNUAL MEETING

References

ATLANTA – Increasingly, data support taking an integrated approach to care in the intervention of first-episode psychosis.

But what are the key components of such treatment?

Dr. Charles Schulz, who initiated an integrated care clinic for first-episode psychosis at the University of Minnesota, Minneapolis, outlined the steps in an integrated care approach.

In an interview at the annual meeting of the American Psychiatric Association, Dr. Schulz reviewed the importance of intervening in the prodromal phase whenever possible, as well as offering cognitive-behavioral and remediation therapies along with medication management.

He also addressed the need for family psychoeducation and group therapy. And Dr. Schulz explained what to do when there might be a differential that manifests with psychiatric presentations that are not psychosis.

Dr. Schulz said he has industry relationships with Forum Pharmaceuticals and Myriad.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

wmcknight@frontlinemedcom.com

On Twitter @whitneymcknight

Recommended Reading

Calibration of schizophrenia treatment is a delicate balancing act
MDedge Internal Medicine
Psychosis: First-episode variety in adolescence ‘insidious’
MDedge Internal Medicine
Psychosis: Watch for sudden poor academic performance
MDedge Internal Medicine
VIDEO: Lifestyle intervention blocks antipsychotic-associated weight gain
MDedge Internal Medicine
Prepsychosis links with elevated metabolic syndrome
MDedge Internal Medicine
Suicidal ideation: An 18-year-old male presents in crisis
MDedge Internal Medicine
Suicidal ideation: Team-based care requires knowledge, resources
MDedge Internal Medicine
FDA approves first drug to treat hallucinations in Parkinson’s psychosis
MDedge Internal Medicine
Aripiprazole linked to rare but serious compulsion problems
MDedge Internal Medicine
FDA: Olanzapine can cause serious skin reaction
MDedge Internal Medicine